Moderna shares plunge after leak of cancer vaccine data despite positive results
Moderna shares fell sharply after leaked cancer vaccine data despite positive clinical trial results showing meaningful benefits when paired with Merck’s immunotherapy.
As the U.S.-Iran war heats up again, these parts of the stock market and economy could be affected
Escalating U.S.-Iran military conflict has prompted Wall Street to reassess economic impacts, with concerns centered on rising energy prices and potential effects on consumer spending and corporate earnings.
Earnings beats are now the norm. What the stock market needs to keep rallying
Third-quarter earnings season begins with major bank reports, as consensus forecasts call for nearly 30% year-over-year profit growth. Tech earnings and guidance will be critical to sustaining the market rally.
Levi Strauss hikes profit guidance after tariff refunds, but its sales outlook is less optimistic
Levi Strauss raised full-year profit guidance to $1.54-$1.56 per share, boosted by tariff refunds, but lowered revenue growth expectations to 7% following weak quarterly sales.
Samsung forecasts record third-quarter profit of $80 billion as AI boom fuels chip demand
Samsung reported record third-quarter operating profit of 107.40 trillion won ($80.2 billion), driven by strong artificial intelligence-related chip demand, though stock price declined despite the results.
PepsiCo cuts earnings forecast as North American turnaround takes longer than expected
PepsiCo reported third-quarter earnings above expectations but cut its full-year earnings forecast as its struggling North American business recovers slower than anticipated.